Trends and inequities in amenable mortality between 1997 and 2012 in South Africa by Neethling, I et al.
597       August 2019, Vol. 109, No. 8
RESEARCH
South Africa (SA) has high rates of mortality across four broad 
causes, with disparities among provinces and population groups.[1] The 
epidemiology of cause of death and area of public health concern, 
and priority required to address the mortality burden, are well known.[1] 
However, an indicator of health system performance is required to 
determine to what extent inadequate healthcare, as opposed to 
behavioural or socioeconomic factors, is responsible for the high 
levels of mortality and health disparities. This would also be use­
ful in the context of the United Nations Sustainable Development 
Goals target 3.8[2] to achieve universal health coverage for all by 2030, 
and the Lancet Global Health Commission on High Quality Health 
Systems, which identified that quality of care should improve across 
conditions and countries.[3] 
Avoidable mortality was introduced in the 1970s as an indicator 
of all deaths considered amenable to healthcare, warranting medical 
audit.[4] The concept has since been applied mostly as an assessment 
of health system performance at the population level, with the 
premise that amenable causes of death should not occur in the 
presence of timely and effective healthcare.[5,6] The introduction 
of preventable mortality, an indicator of the effectiveness of public 
health interventions, resulted in a split of avoidable mortality into 
amenable and preventable causes.[7] Amenable mortality has been 
used as a metric to assess healthcare performance in population 
studies – mostly in Europe, New Zealand, Australia and the USA.[5,6,8] 
The list of amenable causes of death was adapted from the original list 
by Rutstein et al.[4] to reflect advances in medical technology, as well 
as differences in expert opinion and changing disease profiles across 
geographical regions.[7,9,10]
Amenable mortality levels have generally decreased faster than 
preventable and unavoidable mortality levels.[5,11] Populations with 
poorer socioeconomic status associated with inequities in accessi­
bility and quality of healthcare, have consistently had a higher risk 
of amenable mortality.[12­14] Evidence suggests that this disparity has 
been reduced in countries with universal health coverage.[15­17] 
The concept of amenable mortality is now well established in 
Europe and Australasia, and the National Health Service in the UK 
has included it as a summary indicator of treatment outcomes,[18] 
but there is a dearth of studies assessing amenable mortality in low­ 
and middle­income countries. A recent study, which formed part 
of the reporting of the Lancet Global Commission on High Quality 
Health Systems, compared amenable mortality across the globe 
using mortality data from the 2016 Global Burden of Disease (GBD) 
study.[19] However, GBD mortality estimates have been shown to be 
inaccurate for SA,[1] and the list of amenable conditions used might 
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not be representative of the burden of disease experienced in every 
country.
SA is in the process of implementing National Health Insurance 
(NHI). If this is introduced successfully, amenable mortality could 
be used as an indicator to track NHI performance in reducing health 
disparities over time. Amenable mortality is also used to benchmark 
health system performance between developed countries.[11,20] This 
approach could be adopted by SA and other developing countries 
to establish and compare health system performance between 
countries.
This article reports on research that established an amenable 
cause­of­death list appropriate for SA, and determined the levels, 
trends, geographical distribution, population group differ ences and 
international comparisons of mortality amenable to healthcare.
Methods
Study design
This is a population­based retrospective study of all mortality 
determined to be amenable to healthcare between 1997 and 2012 
in SA. 
Data source
We used the Second SA National Burden of Disease (NBD) study, 
which includes data from 1997 to 2012, adjusted from Statistics 
SA (StatsSA) data. The methods are described in detail elsewhere.[21] 
StatsSA data were adjusted for under­registration of deaths and 
misclassification of HIV/AIDS deaths, lack of detail on cause of 
injury, which was estimated from a national sample of mortuaries, 
and high proportion of ill­defined causes, which were redistributed 
across valid underlying causes. 
The NBD data consist of 140 single causes of death. These were 
re­categorised into amenable causes of death using an age cut­off of 
74 years, because of the difficulty in diagnosing the underlying cause 
of death in older people due to the high level of comorbidities and 
following the methods of Nolte and McKee[5] and Tobias and Yeh.[6] 
Leukaemia and asthma were restricted to an age limit of 44 years. The 
rationale is that asthma and chronic obstructive pulmonary disease 
(COPD) are difficult to distinguish in middle age and older age, 
while evidence suggests that deaths due to leukaemia are amenable 
to healthcare between the ages of 15 and 44 years, as death rates for 
leukaemia have declined substantially between 1960 and 2000 for 
these age groups.[5,6] 
Definition and criteria
The Tobias and Yeh[6] definition of amenable deaths was used, which 
defines amenable mortality as causes of death that should not occur 
in the presence of timely and efficient medical care, and can extend 
life expectancy by >5 years in >50% of cases after treatment initiation. 
Amenable causes of death were considered as indicators of secondary 
prevention or medical care. 
Development of an amenable mortality list
The amenable cause­of­death list used in this study is based on 
the Nolte and McKee[5] and Tobias and Yeh[6] lists, as these were 
developed through published evidence and expert opinion, and have 
been extensively used in other studies.[11,22,23] 
The causes on the two international lists were reviewed by two 
local public health experts using the Nolte and McKee[5] and Tobias 
and Yeh[6] rationale for inclusion. The list was also presented at a 
round­table meeting to experts in public health and clinical care. The 
opinion of disease­specific experts was sought for conditions where 
there was a difference of opinion, and was then regarded as the final 
outcome. 
Analysis
Stata IC­13 (StataCorp., USA) and Microsoft Excel 2013 (Microsoft, 
USA) were used to calculate proportions, age­standardised death 
rates (ASDRs), mean proportional change in ASDR and excess 
mortality. The mid­year population estimates by Dorrington[24] were 
used to calculate ASDRs, and the World Health Organization (WHO) 
population structure was used for age standardisation.[25] 
Amenable mortality trends were analysed by age, sex, year, province 
and population group. Population group was defined according to 
apartheid classifications (Africans, Whites, Asians and Coloureds). 
Inequalities in education, income and welfare still persist along racial 
lines due to the legacy of apartheid. Therefore, population group was 
analysed as a proxy for socioeconomic status. Trends by population 
group were analysed only from 2000 onwards owing to the uncertainty 
of estimates by population groups for the earlier years. HIV/AIDS was 
also removed from the analysis to determine amenable mortality, as 
HIV/AIDS conceals trends in other causes.
Furthermore, excess amenable mortality was analysed. This was 
defined as the number of amenable deaths that could be reduced if 
the observed population had the same age­specific amenable rates as 
those of the population with the lowest rates. The analysis was done 
separately for province and population group. The Western Cape 
and the white population group had the lowest observed ASDRs 
between 2008 and 2012. Firstly, expected mortality was calculated 
by multiplying the ADSR per 100 000 population for the province, 
and population group with the lowest ASDR with the population 
estimates of each province and population group. Excess mortality 
was then calculated as the difference in amenable deaths between the 
observed and expected mortality. Deaths between 2008 and 2012, 
which represent the post­HIV/AIDS mortality peak, were pooled to 
attenuate the year­on­year fluctuations in mortality. 
An international comparison of amenable ASDRs for SA was done 
with countries as reported by the Eurostat working group[20] and 
the Gay et al.[11] study. A direct comparison was made by using the 
amenable list of conditions and standard populations in these studies. 
The 2012 amenable ASDRs for SA were compared with the 2012 
estimates of the 33 Eurostat countries using the Eurostat amenable 
list of causes and the European Union (EU) standard population. 
Eurostat is a European office that provides statistics to the EU. HIV/AIDS 
was included in the Eurostat working group study. However, because 
of the large proportion of HIV/AIDS deaths in the SA data,[1] 
an alternative comparison was made with the Organisation for 
Economic Co­operation and Development (OECD) study that excluded 
HIV/AIDS.[11] For the alternative analysis, the Nolte and McKee[5] 
and Tobias and Yeh[6] lists of amenable mortality, together with the 
OECD 2005 standard population by sex as used by Gay et al.,[11] 
were applied to calculate the ASDR for SA. This was compared with 
the ASDRs for the 31 OECD countries.[11]
Results
The amenable list for SA comprises 45 causes of death, including 
11 communicable causes and 34 non­communicable causes (Table 1). 
A further categorisation of the causes of death indicates that the list 
contains 10 different cancer sites, 10 maternal and perinatal causes, 
4 cardiovascular causes and 6 causes across respiratory, digestive 
and genito­urinary categories. The list contains 5 causes of death 
not included in the Nolte and McKee[5] or Tobias and Yeh[6] lists, 
i.e. HIV/AIDS, sexually transmitted infections (STIs) excluding 
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HIV, intestinal parasites and other vector diseases, encephalitis 
and otitis media. HIV/AIDS was added to the local list because of 
recent evidence indicating that survival is extended by >5 years after 
initiation of antiretroviral (ARV) treatment, regardless of CD4+ cell 
count.[26] STIs, excluding HIV, intestinal parasites and other vector 
diseases, encephalitis and otitis media were excluded from the Nolte 
and McKee[5] and Tobias and Yeh[6] lists owing to the scarcity of these 
causes of death (<0.1% of all deaths) in Europe and Australasia. 
Table 1. Amenable cause-of-death list
NBD cause ICD-10 code (age restrictions)
Tuberculosis A15 ­ A19, B90, U51, U52, J90, J94
HIV/AIDS B20 ­ B24, B33, B45, B59, C46, D84
STIs, excluding HIV A50 (≥1 month),* A51 ­ A53, A54 (≥1 month),* A55 ­ A63, N70 ­ N73, A64
Diarrhoeal diseases A00 ­ A09, K52
Intestinal parasites, other parasitic and vector­
borne diseases
A82, A90 ­ A91, A95, B55 ­ B57, B65, B67 ­ B74, B76 ­ B82, B89
Meningitis and encephalitis A39, G00 ­ G03, G05, A83 ­ A87, G04, G09, G93
Septicaemia A40 ­ A41
Malaria B50 ­ B54
Lower respiratory infections J09 ­ J18, J20 ­ J22, P23 (>6 days),* J86
Upper respiratory infections J00 ­ J06
Otitis media, mastoiditis H65 ­ H66
Maternal haemorrhage O20, O44 ­ O46, O67, O72
Maternal sepsis O85 ­ O86
Hypertension in pregnancy O10 ­ O16
Obstructed labour O64 ­ O66
Abortion O00 ­ O08
Other maternal O21 ­ O43, O47 ­ O48, O60 ­ O63, O68 ­ O71, O73 ­ O75, O80 ­ O84, O87 ­ O92, O94 ­ O96
Preterm birth complications P01, P07, P22, P23 (<6 days),* P25 ­ P28, P29, P52, P61, P77, P80
Birth asphyxia and trauma P02, P03, P10 ­ P15, P20 ­ P21, P24, P50, P90 ­ P91
Sepsis and other infectious conditions of  
the newborn
P35, P36 ­ P39, P60, A33 ­ A35 (<1 month),* A50, A54 (<1 month)*
Other non­infectious conditions in  
the perinatal period
P00, P04, P05, P08, P51, P53 ­ P59, P62 ­ P74, P76, P78 ­ P79, P81 ­ P89, P93 ­ P94
Corpus uteri cancer C54 ­ C55
Melanoma C43
Other skin cancer C44
Breast cancer C50
Cervical cancer C53
Testicular cancer C62
Hodgkin’s lymphoma C81
Leukaemia C91 ­ C95 (<45 years)
Bladder cancer C67
Thyroid cancer C73
Diabetes mellitus E10 ­ E14
Epilepsy G40 ­ G41
Ischaemic heart disease I20 ­ I25
Rheumatic heart disease I00 ­ I09
Hypertensive heart disease I11
Cerebrovascular disease I60 ­ I69, G81
Asthma J45 ­ J46 (<45 years)
Peptic ulcer K25 ­ K27
Appendicitis K35 ­ K37
Intestinal obstruction and strangulated hernia K40 ­ K46, K56
Renal disease N00 ­ N08, N10 ­ N12, N17 ­ N19, I12, I13
Benign prostatic hypertrophy N40
Congenital heart anomalies Q20 ­ Q28
Adverse effects of medical and surgical 
treatment
Y39 ­ Y66, Y68 ­ Y84, Y88
NBD = Second South African National Burden of Disease study; ICD = International Classification of Diseases; STI = sexually transmitted infection.
*Age restrictions of the NBD study.
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Table 2 presents ASDRs, total number of deaths and proportions 
for 2012 – the last year of analysis. In 2012, just ˂320 000 deaths in 
SA were classified as amenable to healthcare, which equates to 60% 
of all deaths. The highest number of amenable deaths occurred in 
KwaZulu­Natal (KZN) Province (N=83 868), followed by Gauteng 
Province (N=58 910). 
Using ASDR, there were huge inequalities in amenable mortality 
between the different provinces and population groups in 2012 
(Table 2). KZN had the highest ASDR (958 per 100 000 population), 
2.5 times higher than the lowest ASDR, which was in the Western 
Cape (378.8 per 100 000 population). The disparities between popu­
lation groups were even wider, with the African population having an 
ASDR 4.4 times higher than that of the white population. 
Deaths amenable to healthcare accounted for >50% of total 
deaths in all provinces, except in the Western Cape (43.9%), while 
Mpumalanga Province had the highest proportion (68.6%). The 
white population had a much lower proportion of amenable mortality 
(26.3%) compared with other population groups (>48%), while the 
African population had the highest proportion (64.8%).
Analysing the trend in amenable mortality between 1997 and 2012, 
a disparity in ASDR by province in 1997 and population group in 
2000 was evident, which widened each subsequent year until 2005 
(Figs 1A and B) and narrowed thereafter. The Western Cape had the 
lowest amenable ASDR over the entire period, while KZN and Free 
State Province had the highest rates (Fig. 1A). The trend was similar 
for all provinces, increasing between 1997 and 2006 and decreasing 
thereafter. The ASDR for SA was 591 per 100 000 in 1997, reached a 
peak (1 074 per 100 000) in 2005 and decreased thereafter (693 per 
100 000) in 2012. The African population had the highest ASDR of 
all population groups over the period, which was 4.6 times that of the 
white population in 1997, increasing to 6.5 times in 2005 (Fig. 1B).
When HIV/AIDS as a cause was excluded from the analysis, the 
ASDR trend decreased for some provinces, such as Eastern Cape 
Province, the Free State and Mpumalanga, but remained fairly stable 
over the period for others (Fig. 1C). There was a decreasing trend in 
ASDR between 2000 and 2012 for all population groups, except for 
the white population, where there was a minimal change (Fig. 1D).
The mean annual percentage change in ASDR, an indicator of the 
pace of change, is presented in Fig. 2. It provides a breakdown of the 
percentage change for SA before and after the HIV/AIDS mortality 
peak, as well as a breakdown with and without HIV/AIDS. SA had 
a mean annual increase of 1.36% in amenable ASDR between 1997 
and 2012, but when HIV/AIDS was removed from the analysis, the 
mean percentage change in ASDR decreased at a rate of 1.12 per 
year. There was a particularly high average increase of 6.9% between 
1997 and 2006, which was reversed to a decrease of 0.05% per year 
when HIV/AIDS was excluded. Between 2007 and 2012, there was an 
annual average decrease in amenable ASDR of 7%, which reduced to 
2.7% when HIV/AIDS was excluded from the analysis.
An average of 207 810 amenable deaths per year could have been 
averted in SA between 2008 and 2012 if all provinces had the same 
amenable mortality rate as the Western Cape (Fig. 3A). KZN had the 
highest excess amenable mortality of all provinces (70 257 deaths). 
If all population groups had the same amenable mortality rate as the 
white population, an average of 300 000 deaths per year between 2008 
and 2012 could have been averted. The African population group 
accounted for 95% of all excess deaths. Males and females accounted 
for similar numbers of excess amenable deaths across provinces and 
population groups (Fig. 3B).
The amenable ASDRs from SA were compared with those of 
countries assessed in the Eurostat working group and Gay et al.[11] 
studies by using the lists of amenable conditions and standard 
populations from these studies (Figs 4A and B).[11,20] There were huge 
disparities in ASDRs between SA and the other countries. The ASDR 
for SA was 2.6 times higher than that of the Eurostat working group 
country with the highest ASDR and 11.5 times higher than that of 
the country with the lowest ASDR for 2012 (Fig. 4A). The ASDR for 
SA was 2.2 times higher than that of the worst­performing OECD 
country, using the Tobias and Yeh[6] list, and 1.8 times higher than that 
of the worst­performing country using the Nolte and McKee[5] list.
Discussion 
To the best of our knowledge, this study of the epidemiology of 
amenable mortality in SA is the first to be reported. The local 
amenable cause­of­death list contains more causes of death than the 
frequently used lists of Nolte and McKee[5] and Tobias and Yeh,[6] 
reflecting the quadruple burden of disease in SA, with high rates 
of infectious and non­infectious diseases. The local list includes 
causes such as HIV/AIDS, STIs excluding HIV/AIDS, and intestinal 
parasites and vector diseases, which are not present in the other lists. 
Table 2. Age-standardised death rates, deaths and amenable death proportions by province and population group, 2012
ASDR Deaths Proportion*
Province
KwaZulu­Natal 958.4 83 868.8 65.6
Free State 854.1 20 714.8 63.2
Mpumalanga 851.0 28 751.2 68.6
Eastern Cape 782.2 45 220.9 57.4
North West 765.1 24 565.1 64.1
Northern Cape 706.7 7 158.5 58.0
Limpopo 641.1 28 972.6 61.9
Gauteng 536.8 58 910.7 56.8
Western Cape 378.8 20 372.4 43.9
South Africa 692.9 318 534.9 60.2
Population group
African 827.6 284 326.0 64.8
Coloured 436.8 17 827.1 49.8
Asian 337.9 4 559.6 48.7
White 186.8 11 822.1 26.3
ASDR = age­standardised death rate.
*Amenable mortality proportion of all mortality for each province and population group separately.
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HIV/AIDS was not included in amenable cause­of­death lists until 
recently, when the Eurostat[20] study included it in both amenable and 
preventable cause lists. Triple­therapy ARVs have been available 
since the mid­1990s, but only recently has evidence emerged that 
the life expectancy of individuals with HIV/AIDS after initia tion 
of ARVs is ~80% of the life expectancy of people without HIV/
AIDS.[26]
The high proportion and ASDRs indicate an ineffective healthcare 
system overwhelmed by a high burden of disease. The HIV/AIDS 
epidemic placed immense strain on the health system and is likely 
to have detracted healthcare supply from other health conditions. 
People with HIV/AIDS occupied a large proportion of available 
hospital beds, and the prevalence of HIV/AIDS in the health 
workforce was estimated at 16 ­ 20% in 2006.[27] This could explain 
the relatively low average annual decline of 1.12% in amenable 
mortality rates compared with those of other countries when HIV/AIDS 
is excluded from the analyses. For instance, in the Gay et al.[11] study, 
the average annual decline in amenable ASDR was 3.5% between 
1997 and 2007, while countries with an above­average amenable 
ASDR in 1997 showed a higher rate of decline. After the peak in HIV/
AIDS mortality in 2006, there does appear to be an improvement 
in the performance of the health system, with rates of amenable 
causes steadily decreasing at an average annual rate of 7%, and 
2.7% when HIV/AIDS is excluded from the analysis. The decrease 
in amenable mortality after 2006 when ARVs were introduced 
into the healthcare system in SA is due largely to HIV/AIDS. The 
rapidly reducing HIV/AIDS mortality probably also had an indirect 
positive impact on the quality of care for other amenable causes 
during this period. Furthermore, there have been some government 
initiatives to reduce the burden of disease following a change in 
health sector leadership in 2009, as described by Mayosi et al.,[28] 
which may have contributed to the improved amenable mortality 
rates.
There were huge disparities in amenable mortality between 
provinces and population groups, which did not attenuate much 
over a 15­year period. To reduce the disparity, causes other than 
HIV/AIDS also need to decline. Although the pace of decline in 
amenable mortality excluding HIV/AIDS improved after 2006 in 
most provinces and population groups, it did not occur in a pattern 
that would reduce the disparities between provinces and population 
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Fig. 1. Trend in age-standardised amenable mortality by: (A) province 
between 1997 and 2012; (B) population group between 2000 and 2012; 
(C) province, excluding HIV/AIDS; and (D) population group, excluding 
HIV/AIDS. (WC = Western Cape; EC = Eastern Cape; NC = Northern 
Cape; FS = Free State; KZN = KwaZulu-Natal; NW = North West; GT = 
Gauteng; MP = Mpumalanga; LP = Limpopo; SA = South Africa.)
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Fig. 2. Comparison of mean annual percentage change in ASDR in South 
Africa across different time periods, with and excluding HIV/AIDS. (ASDR = 
age-standardised death rate; excl. = excluding.)
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groups over time. For instance, in 1997, KZN 
had the fourth­largest amenable mortality 
ASDR excluding HIV/AIDS, but the mean 
annual decrease was the third­lowest for all 
provinces. In the same year, Limpopo had 
the third­lowest amenable mortality ASDR, 
but the third­lowest mean annual decrease.
The high rates of amenable mortality 
could be related to the inefficient distribution 
of public and private care, with an estimated 
85% of the population dependant on public 
health services while the distribution of 
healthcare is skewed towards private care.[29] 
Inequitable healthcare financing probably 
also played a role in the disparity in amenable 
mortality between the different provinces 
and population groups. Health financing 
has been shown to be inversely proportional 
to need at district and sub­district level.[30,31] 
This disparity in healthcare financing 
is perpetuated by a greater allocation of 
funding to provinces with a higher number 
of private hospitals and doctors.[32] This 
might explain the better amenable mortality 
outcome in the Western Cape and Gauteng 
compared with that in other provinces, as 
these two provinces have more private and 
public hospitals, a higher number of doctors 
per person, as well as a greater proportion of 
people who are medically insured.[32,33]
Socioeconomic status appears to intersect 
with population group, with the white 
population having the highest average levels 
of wealth and using mostly private healthcare 
facilities compared with other racial groups, 
the majority of whom use public health 
facilities.[29] Barriers to healthcare are greater 
for Africans, the uninsured, the poor and 
rural residents, for whom travel costs and 
travel distances are some key barriers.[34] 
Rates for the white population did not change 
much over time, but decreased for other 
population groups. This might be owing to 
the low baseline amenable mortality rates 
among whites from the start, but could also 
indicate that access to quality healthcare for 
whites has decreased over the period or that 
quality of healthcare for other population 
groups has improved. 
The excess death approach is a useful 
measure, as it calculates the number of 
amenable deaths that could have been 
prevented if health system performance was 
at the same level as the best­performing 
province or population group. The largest 
number of excess amenable deaths occurred 
in KZN and in the African population, and 
gives an indication of the impact that can be 
made by reducing amenable mortality in the 
most vulnerable groups.
The pending NHI is intended to supply 
essential healthcare to all legal residents and 
could potentially aid in reducing amenable 
mortality levels, as well as the disparities 
in amenable mortality between provinces 
and population groups. Universal healthcare 
has been effective in reducing inequities 
in amenable mortality, e.g. in Canada, the 
difference in amenable mortality decreased 
by 60 ­ 78% between the richest and poorest 
neighbourhoods between 1971 and 1996 
after the introduction of universal healthcare, 
while similar findings have been shown in 
the UK and Australia.[15­17]
The benchmarking of SA against 
countries analysed in the Gay et al.[11] and 
Euro stat[20] studies reveals a health system 
that is performing poorly. However, the 
comparison might be unfair, as these are 
mostly high­income countries. SA’s relatively 
poor health performance was also shown in 
a study that compared Brazil, Russia, India, 
China and SA with the economic peers 
of each country. SA performed the worst 
over a 20­year period.[35] This study showed 
declining health performance in SA, with 
excess years of life lost (YLLs), calculated 
as the difference between actual YLLs and 
YLLs in the best­performing country, which 
increased sharply between 1990 and 2011. 
There are some limitations to the use 
of amenable mortality as an indicator of 
health system performance that have been 
documented elsewhere.[36,37] The measure 
does not account for factors outside the 
scope of healthcare that could influence 
amenable mortality, such as socioeconomic 
circumstances. It does not allow for an 
assessment of morbidity or provide for plans 
to improve the health system. The list of 
amenable causes should be regularly reviewed 
to include those that have become amenable 
owing to advances in medical technology.
Some limitations specific to this study are 
that the NBD data are based on statistical 
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modelling approaches using various assump tions. However, the 
estimates have been vali dated against other data sources and are an 
improvement on the StatsSA data. HIV/AIDS was categorised as an 
amenable cause of death even though ARVs were only introduced 
to the SA health system in 2006. However, SA chose not to provide 
ARVs before 2006 and health system performance should be assessed 
on the best­available healthcare. We were unable to do a comparison 
with the global list of countries assessed in the Lancet Global 
Commission on High Quality Health Systems study[19] because they 
reported on 2016 mortality data, which are not represented in the 
NBD data; they did not report age­standardised rates. 
Conclusions
Amenable mortality could be used as an indicator to monitor and 
evaluate the performance of SA’s health system. This is especially 
relevant in light of the pending NHI. In combination with other 
indicators, such as resource allocation and service coverage, amenable 
mortality could provide important insight into the success of NHI 
reforms. It could track progress in reducing geographical and racial 
inequities and identify priority areas of the health system that 
require improvement. Ideally, amenable mortality should be routinely 
monitored at district and sub­district levels, each of which may 
require a different set of targets and benchmarks. At facility level, it 
could be used as a tool to investigate and conduct reviews of each 
amenable death. As a globally recognised metric, it is important to 
track progress of overall amenable mortality levels at national level 
compared with those of other countries. The ASDR level and annual 
percentage change in amenable mortality should be used together 
to assess performance, while the list of amenable causes should 
be reviewed on a continuous basis. Ultimately, there is a need to 
develop the capability to conduct and integrate amenable mortality 
assessments into the NHI system.
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